• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

近期对 HIV-1 中 Fc 介导的效应器反应的深入了解。

Recent insights into Fc-mediated effector responses to HIV-1.

机构信息

Thayer School of Engineering, Dartmouth College.

Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.

出版信息

Curr Opin HIV AIDS. 2020 Sep;15(5):282-289. doi: 10.1097/COH.0000000000000638.

DOI:10.1097/COH.0000000000000638
PMID:32675573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7732205/
Abstract

PURPOSE OF REVIEW

Recent work defining Fc-mediated effector functions for both viral control and protection against infection is summarized and considered along with new strategies to drive robust Fc-mediated responses.

RECENT FINDINGS

In new human and nonhuman primate (NHP) vaccine trials as well as studies of natural infection, Fc-mediated effector responses have sometimes been observed to correlate with decreased risk of infection or with better clinical outcomes, suggesting a potential role for these responses in HIV-1 prevention and therapy. Recent highlights include use of antibody-dependent cellular cytotoxicity-sensitizing CD4-induced mimetic compounds, novel V1V2 immunogens, passive transfer studies, and vaccine regimens that successfully elicited Fc-mediated responses and were reported to decrease risk of infection in challenge studies in NHPs. Lastly, detailed studies of IgG3 forms of HIV-specific antibodies have reported that both neutralizing and Fc-mediated responses can be increased relative to the more prevalent IgG1 subclass.

SUMMARY

Successful harmonization of neutralizing and Fc-mediated responses may make key contributions to the goal of reducing HIV-1 infection via active and passive vaccination. New studies continue to highlight the importance of Fc-mediated antibody responses as correlates of decreased risk of infection and suggest enhanced phagocytosis is a potential mechanism of reduced risk of infection associated with human IgG3 responses. Results from recent studies may help guide the rational design of therapies and vaccines that aim to specifically leverage antibody effector function.

摘要

目的综述

总结了最近关于 Fc 介导的效应功能在病毒控制和感染保护方面的研究,并结合新策略来促进强大的 Fc 介导的反应进行了讨论。

最近的发现

在新的人体和非人灵长类动物(NHP)疫苗试验以及自然感染研究中,Fc 介导的效应反应有时与降低感染风险或更好的临床结果相关,这表明这些反应可能在 HIV-1 的预防和治疗中发挥作用。最近的亮点包括使用抗体依赖性细胞毒性敏感的 CD4 诱导模拟化合物、新型 V1V2 免疫原、被动转移研究以及疫苗方案,这些方案成功地引起了 Fc 介导的反应,并据报道在 NHP 的挑战研究中降低了感染风险。最后,对 HIV 特异性抗体 IgG3 形式的详细研究报告称,与更常见的 IgG1 亚类相比,中和和 Fc 介导的反应都可以增加。

总结

成功协调中和和 Fc 介导的反应可能对通过主动和被动免疫接种降低 HIV-1 感染的目标做出重要贡献。新的研究继续强调 Fc 介导的抗体反应作为降低感染风险的相关因素的重要性,并表明增强吞噬作用可能是与人类 IgG3 反应相关的感染风险降低的潜在机制。最近研究的结果可能有助于指导旨在专门利用抗体效应功能的治疗和疫苗的合理设计。

相似文献

1
Recent insights into Fc-mediated effector responses to HIV-1.近期对 HIV-1 中 Fc 介导的效应器反应的深入了解。
Curr Opin HIV AIDS. 2020 Sep;15(5):282-289. doi: 10.1097/COH.0000000000000638.
2
Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.一种模拟CD4的微小蛋白质与HIV-1包膜糖蛋白gp140的交联改变了猕猴体内针对HIV-1包膜的抗体反应动力学和特异性。
J Virol. 2017 Sep 12;91(19). doi: 10.1128/JVI.00401-17. Print 2017 Oct 1.
3
Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models.在兔和恒河猴动物模型中桥接疫苗诱导的 HIV-1 中和和效应抗体反应。
J Virol. 2019 May 1;93(10). doi: 10.1128/JVI.02119-18. Print 2019 May 15.
4
Reduced Cell-Associated DNA and Improved Viral Control in Macaques following Passive Transfer of a Single Anti-V2 Monoclonal Antibody and Repeated Simian/Human Immunodeficiency Virus Challenges.在单次被动转移抗 V2 单克隆抗体和重复猴/人免疫缺陷病毒挑战后,猕猴体内细胞相关 DNA 减少和病毒控制得到改善。
J Virol. 2018 May 14;92(11). doi: 10.1128/JVI.02198-17. Print 2018 Jun 1.
5
Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects.在HIV感染和接种疫苗的受试者中观察到的抗病毒IgG效应活性的多样性。
J Immunol. 2016 Dec 15;197(12):4603-4612. doi: 10.4049/jimmunol.1601197. Epub 2016 Nov 9.
6
Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization.HIV-1 中和作用以外的 Fc 介导的抗体功能更新。
Front Immunol. 2019 Dec 18;10:2968. doi: 10.3389/fimmu.2019.02968. eCollection 2019.
7
A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.一种三聚体HIV-1包膜糖蛋白120免疫原在兔和恒河猴中诱导出针对HIV-1的强效且广谱的抗V1V2环抗体。
J Virol. 2018 Feb 12;92(5). doi: 10.1128/JVI.01796-17. Print 2018 Mar 1.
8
Qualitative and quantitative variables that affect the potency of Fc- mediated effector function in vitro and in vivo: considerations for passive immunization using non-neutralizing antibodies.影响Fc介导的体外和体内效应功能效力的定性和定量变量:使用非中和抗体进行被动免疫的考量
Curr HIV Res. 2013 Jul;11(5):354-64. doi: 10.2174/1570162x113116660060.
9
HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies.在感染早期,HIV 特异性 Fc 效应功能可预测广泛中和抗体的产生。
PLoS Pathog. 2018 Apr 9;14(4):e1006987. doi: 10.1371/journal.ppat.1006987. eCollection 2018 Apr.
10
Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women.局部应用替诺福韦前暴露预防和女性黏膜 HIV 特异性 Fc 介导的抗体活性。
Front Immunol. 2020 Jul 6;11:1274. doi: 10.3389/fimmu.2020.01274. eCollection 2020.

引用本文的文献

1
Chimeric receptor-binding domain vaccine design and sequential immunization enhanced broadly neutralizing antibody responses against COVID-19.嵌合受体结合域疫苗设计与序贯免疫增强了针对新冠病毒的广泛中和抗体反应。
Front Immunol. 2025 Mar 27;16:1543212. doi: 10.3389/fimmu.2025.1543212. eCollection 2025.
2
Tailoring T profiles enhances antibody persistence to a clade C HIV-1 vaccine in rhesus macaques.定制 T 细胞表位可增强恒河猴对 HIV-1 疫苗的抗体持久性。
Elife. 2024 Feb 22;12:RP89395. doi: 10.7554/eLife.89395.
3
Vaccination with immune complexes modulates the elicitation of functional antibodies against HIV-1.

本文引用的文献

1
Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody.Fc 介导的效应功能有助于 HIV 中和抗体的体内抗病毒作用。
Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18754-18763. doi: 10.1073/pnas.2008236117. Epub 2020 Jul 20.
2
Improved killing of HIV-infected cells using three neutralizing and non-neutralizing antibodies.使用三种中和和非中和抗体提高杀伤感染 HIV 的细胞的效果。
J Clin Invest. 2020 Oct 1;130(10):5157-5170. doi: 10.1172/JCI135557.
3
Oral Immunization with HIV-1 Envelope SOSIP trimers elicits systemic immune responses and cross-reactive anti-V1V2 antibodies in non-human primates.
接种免疫复合物可调节针对 HIV-1 的功能性抗体的产生。
Front Immunol. 2023 Oct 3;14:1271686. doi: 10.3389/fimmu.2023.1271686. eCollection 2023.
4
Fc receptor engagement of HIV-1 Env-specific antibodies in mothers and infants predicts reduced vertical transmission.母体和婴儿中 HIV-1 Env 特异性抗体的 Fc 受体结合可预测垂直传播减少。
Front Immunol. 2022 Dec 12;13:1051501. doi: 10.3389/fimmu.2022.1051501. eCollection 2022.
5
Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection.母体 Fc 介导的非中和抗体反应与预防先天性人巨细胞病毒感染相关。
J Clin Invest. 2022 Aug 15;132(16). doi: 10.1172/JCI156827.
6
Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features.独特的生物物理抗体特征可预测多样化的抗病毒 IgG 效应活性。
Retrovirology. 2021 Oct 30;18(1):35. doi: 10.1186/s12977-021-00579-9.
7
Broadly Neutralizing Antibodies for HIV-1 Prevention.广谱中和抗体在 HIV-1 预防中的应用。
Front Immunol. 2021 Jul 20;12:712122. doi: 10.3389/fimmu.2021.712122. eCollection 2021.
口服免疫 HIV-1 包膜 SOSIP 三聚体可在非人类灵长类动物中引发全身性免疫反应和交叉反应性抗 V1V2 抗体。
PLoS One. 2020 May 29;15(5):e0233577. doi: 10.1371/journal.pone.0233577. eCollection 2020.
4
Elicitation of Cluster A and Co-Receptor Binding Site Antibodies are Required to Eliminate HIV-1 Infected Cells.需要诱导A簇和共受体结合位点抗体来清除HIV-1感染的细胞。
Microorganisms. 2020 May 11;8(5):710. doi: 10.3390/microorganisms8050710.
5
Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge.在相同解剖部位同时接种DNA和蛋白质可诱导针对SHIV攻击的更强保护性免疫反应。
Cell Rep. 2020 May 12;31(6):107624. doi: 10.1016/j.celrep.2020.107624.
6
Maternal Anti-Dengue IgG Fucosylation Predicts Susceptibility to Dengue Disease in Infants.母体抗登革热IgG岩藻糖基化可预测婴儿患登革热疾病的易感性。
Cell Rep. 2020 May 12;31(6):107642. doi: 10.1016/j.celrep.2020.107642.
7
Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies.来自马尔堡感染幸存者的非中和抗体通过 Fc 效应功能介导保护,并增强其他抗体的效力。
Cell Host Microbe. 2020 Jun 10;27(6):976-991.e11. doi: 10.1016/j.chom.2020.03.025. Epub 2020 Apr 21.
8
Induction of cross-reactive HIV-1 specific antibody responses by engineered V1V2 immunogens with reduced conformational plasticity.通过降低构象灵活性的工程化 V1V2 免疫原诱导交叉反应性 HIV-1 特异性抗体应答。
Vaccine. 2020 Apr 16;38(18):3436-3446. doi: 10.1016/j.vaccine.2020.03.010. Epub 2020 Mar 17.
9
Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies.铰链长度影响 HIV 特异性 IgG1 和 IgG3 抗体的吞噬活性。
PLoS Pathog. 2020 Feb 24;16(2):e1008083. doi: 10.1371/journal.ppat.1008083. eCollection 2020 Feb.
10
Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.南非 HVTN 100 中健康 HIV 阴性成人 12 个月加强免疫后的安全性和免疫应答:ALVAC-HIV(vCP2438)和二价 C 亚型 gp120/MF59 疫苗的随机双盲安慰剂对照试验。
PLoS Med. 2020 Feb 24;17(2):e1003038. doi: 10.1371/journal.pmed.1003038. eCollection 2020 Feb.